| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10463 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DBI mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of DBI mRNA | CTD | PMID:17108234 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:10463 | 6480464 | Dihydrotestosterone results in increased expression of DBI mRNA | CTD | PMID:16963002 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10463 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DBI mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10463 | 6480464 | Tetrachlorodibenzodioxin affects the expression of DBI mRNA | CTD | PMID:21570461 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of DBI mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:10463 | 6480464 | Glucosamine results in increased expression of DBI mRNA | CTD | PMID:17178593 |
| 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of DBI mRNA | CTD | PMID:19483382 |
| 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DBI mRNA | CTD | PMID:12376462 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:10463 | 6480464 | Glucosamine results in increased expression of DBI mRNA | CTD | PMID:17178593 |
| amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of DBI mRNA | CTD | PMID:19483382 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of DBI mRNA | CTD | PMID:16483693 |
| benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of DBI mRNA | CTD | PMID:19483382 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10463 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of DBI mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:10463 | 6480464 | Benzo(a)pyrene results in increased expression of DBI mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10463 | 6480464 | Benzo(a)pyrene results in decreased expression of DBI mRNA | CTD | PMID:22228805 |
| benzo[b]fluoranthene | decreases expression | ISO | RGD:736302 | 6480464 | benzo(b)fluoranthene results in decreased expression of DBI mRNA | CTD | PMID:16269432 |
| beta-D-glucosamine | increases expression | ISO | RGD:10463 | 6480464 | Glucosamine results in increased expression of DBI mRNA | CTD | PMID:17178593 |
| bezafibrate | increases expression | ISO | RGD:10463 | 6480464 | Bezafibrate results in increased expression of DBI mRNA | CTD | PMID:17118139 |
| bifenthrin | multiple interactions | EXP | | 6480464 | bifenthrin analog inhibits the reaction [CGA results in increased expression of DBI mRNA] | CTD | PMID:21871944 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:10463 | 6480464 | Diethylhexyl Phthalate results in increased expression of DBI mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:10463 | 6480464 | Diethylhexyl Phthalate results in increased expression of DBI mRNA | CTD | PMID:19245819 PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:10463 | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of DBI mRNA] | CTD | PMID:19850644 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of DBI promoter | CTD | PMID:22457795 |
| clofibrate | increases expression | ISO | RGD:10463 | 6480464 | Clofibrate results in increased expression of DBI mRNA | CTD | PMID:17585979 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of DBI mRNA | CTD | PMID:8499488 PMID:12851107 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of DBI mRNA | CTD | PMID:12851107 PMID:8499488 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of DBI mRNA; more ... | CTD | PMID:8499488 |
| clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of DBI mRNA | CTD | PMID:19483382 |
| clofibrate | multiple interactions | ISO | RGD:10463 | 6480464 | PPARA protein affects the reaction [Clofibrate results in increased expression of DBI mRNA]; more ... | CTD | PMID:17585979 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DBI mRNA | CTD | PMID:17602206 |
| cobalt dichloride | decreases expression | ISO | RGD:736302 | 6480464 | cobaltous chloride results in decreased expression of DBI mRNA | CTD | PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:736302 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of DBI mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:736302 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of DBI mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:736302 | 6480464 | Copper Sulfate results in decreased expression of DBI mRNA | CTD | PMID:19549813 |
| corticosterone | increases expression | ISO | RGD:10463 | 6480464 | Corticosterone results in increased expression of DBI mRNA | CTD | PMID:16963002 |
| cyclosporin A | decreases expression | ISO | RGD:736302 | 6480464 | Cyclosporine results in decreased expression of DBI mRNA | CTD | PMID:20106945 |
| D-glucose | increases expression | ISO | RGD:10463 | 6480464 | Glucose results in increased expression of DBI mRNA | CTD | PMID:17178593 |
| dibenz[a,h]anthracene | decreases expression | ISO | RGD:736302 | 6480464 | 1,2,5,6-dibenzanthracene results in decreased expression of DBI mRNA | CTD | PMID:16269432 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of DBI mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of DBI mRNA | CTD | PMID:17379624 PMID:21266533 |
| disodium selenite | increases expression | ISO | RGD:736302 | 6480464 | Sodium Selenite results in increased expression of DBI mRNA | CTD | PMID:18175754 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:10463 | 6480464 | [docetaxel co-treated with Doxorubicin] results in increased expression of DBI protein | CTD | PMID:20457137 |
| doxorubicin | multiple interactions | ISO | RGD:10463 | 6480464 | [docetaxel co-treated with Doxorubicin] results in increased expression of DBI protein | CTD | PMID:20457137 |
| fenofibrate | increases expression | ISO | RGD:10463 | 6480464 | Fenofibrate results in increased expression of DBI mRNA | CTD | PMID:17118139 |
| glucose | increases expression | ISO | RGD:10463 | 6480464 | Glucose results in increased expression of DBI mRNA | CTD | PMID:17178593 |
| hydralazine | multiple interactions | ISO | RGD:736302 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of DBI mRNA | CTD | PMID:17183730 |
| isotretinoin | decreases expression | ISO | RGD:736302 | 6480464 | Isotretinoin results in decreased expression of DBI mRNA | CTD | PMID:20436886 |
| L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of DBI mRNA | CTD | PMID:19483382 |
| maneb | multiple interactions | ISO | RGD:10463 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of DBI mRNA | CTD | PMID:18386188 |
| menadione | affects expression | ISO | RGD:736302 | 6480464 | Vitamin K 3 affects the expression of DBI mRNA | CTD | PMID:20044591 |
| methotrexate | affects expression | ISO | RGD:10463 | 6480464 | Methotrexate affects the expression of DBI mRNA | CTD | PMID:18502557 |
| methylazoxymethanol | increases expression | ISO | RGD:10463 | 6480464 | methylazoxymethanol results in increased expression of DBI mRNA | CTD | PMID:17107856 |
| myristoyl-CoA | affects binding | ISO | RGD:736302 | 6480464 | S-tetradecanoyl-coenzyme A binds to DBI protein | CTD | PMID:17044054 |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of DBI mRNA | CTD | PMID:16525678 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DBI mRNA | CTD | PMID:17602206 |
| nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of DBI mRNA | CTD | PMID:22110744 |
| omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of DBI mRNA | CTD | PMID:19483382 |
| paracetamol | multiple interactions | ISO | RGD:10463 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DBI mRNA] | CTD | PMID:17585979 |
| paracetamol | decreases expression | ISO | RGD:736302 | 6480464 | Acetaminophen results in decreased expression of DBI mRNA | CTD | PMID:21420995 |
| paraquat | multiple interactions | ISO | RGD:10463 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of DBI mRNA | CTD | PMID:18386188 |
| perfluorodecanoic acid | increases expression | EXP | | 6480464 | perfluorodecanoic acid results in increased expression of DBI mRNA; more ... | CTD | PMID:8499488 |
| perfluorooctanoic acid | affects expression | ISO | RGD:10463 | 6480464 | perfluorooctanoic acid affects the expression of DBI mRNA | CTD | PMID:18281256 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of DBI mRNA; more ... | CTD | PMID:8499488 |
| perfluorooctanoic acid | increases expression | ISO | RGD:10463 | 6480464 | perfluorooctanoic acid results in increased expression of DBI mRNA | CTD | PMID:17681415 |
| pirinixic acid | increases expression | ISO | RGD:10463 | 6480464 | pirinixic acid results in increased expression of DBI mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | ISO | RGD:10463 | 6480464 | pirinixic acid results in increased expression of DBI mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | ISO | RGD:10463 | 6480464 | pirinixic acid results in increased expression of DBI mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | increases expression | ISO | RGD:10463 | 6480464 | pirinixic acid results in increased expression of DBI mRNA | CTD | PMID:17118139 more ... |
| pirinixic acid | increases expression | ISO | RGD:10463 | 6480464 | pirinixic acid results in increased expression of DBI mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | increases expression | ISO | RGD:10463 | 6480464 | pirinixic acid results in increased expression of DBI mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of DBI mRNA | CTD | PMID:19162173 |
| pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of DBI mRNA | CTD | PMID:19483382 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | pirinixic acid promotes the reaction [[PPARA protein binds to MDM2 protein] which binds to DBI promoter] | CTD | PMID:19103650 |
| pirinixic acid | multiple interactions | ISO | RGD:10463 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of DBI mRNA] | CTD | PMID:20059764 |
| progesterone | affects expression | ISO | RGD:10463 | 6480464 | Progesterone affects the expression of DBI mRNA | CTD | PMID:17251523 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:736302 | 6480464 | tert-Butylhydroperoxide results in decreased expression of DBI mRNA | CTD | PMID:15336504 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of DBI mRNA | CTD | PMID:16644059 |
| tetracycline | decreases expression | ISO | RGD:10463 | 6480464 | Tetracycline results in decreased expression of DBI mRNA | CTD | PMID:16917069 |
| thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of DBI mRNA | CTD | PMID:19483382 |
| troglitazone | increases expression | ISO | RGD:10463 | 6480464 | troglitazone results in increased expression of DBI mRNA | CTD | PMID:12732648 |
| valproic acid | multiple interactions | ISO | RGD:736302 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of DBI mRNA | CTD | PMID:17183730 |
| valproic acid | affects expression | ISO | RGD:10463 | 6480464 | Valproic Acid affects the expression of DBI mRNA | CTD | PMID:17292431 |